Form 8-K - Current report:
SEC Accession No. 0001558370-25-008694
Filing Date
2025-06-17
Accepted
2025-06-17 17:00:24
Documents
13
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20250617x8k.htm   iXBRL 8-K 46434
  Complete submission text file 0001558370-25-008694.txt   161636

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20250617.xsd EX-101.SCH 3975
3 EX-101.DEF tmb-20250617_def.xml EX-101.DEF 2806
4 EX-101.LAB tmb-20250617_lab.xml EX-101.LAB 16547
5 EX-101.PRE tmb-20250617_pre.xml EX-101.PRE 9655
15 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250617x8k_htm.xml XML 4679
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 251054127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)